Hypoalbuminemia and Early Mortality After Lung Transplantation: A Cohort Study

Hypoalbuminemia predicts disability and mortality in patients with various illnesses and in the elderly. The association between serum albumin concentration at the time of listing for lung transplantation and the rate of death after lung transplantation is unknown. We examined 6808 adults who underwent lung transplantation in the United States between 2000 and 2008. We used Cox proportional hazard models and generalized additive models to examine multivariable‐adjusted associations between serum albumin and the rate of death after transplantation. The median follow‐up time was 2.7 years. Those with severe (0.5–2.9 g/dL) and mild hypoalbuminemia (3.0–3.6 g/dL) had posttransplant adjusted mortality rate ratios of 1.35 (95% CI: 1.12–1.62) and 1.15 (95% CI: 1.04–1.27), respectively. For each 0.5 g/dL decrease in serum albumin concentration the 1‐year and overall mortality rate ratios were 1.48 (95% CI: 1.21–1.81) and 1.26 (95% CI: 1.11–1.43), respectively. The association between hypoalbuminemia and posttransplant mortality was strongest in recipients with cystic fibrosis and interstitial lung disease. Hypoalbuminemia is an independent risk factor for death after lung transplantation.

[1]  Douglas E Schaubel,et al.  Sarcopenia and mortality after liver transplantation. , 2010, Journal of the American College of Surgeons.

[2]  Patrick J Heagerty,et al.  Development of a predictive model for long-term survival after lung transplantation and implications for the lung allocation score. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[3]  M. Makary,et al.  Frailty as a predictor of surgical outcomes in older patients. , 2010, Journal of the American College of Surgeons.

[4]  M. Bacchetta,et al.  Obesity and underweight are associated with an increased risk of death after lung transplantation. , 2009, American journal of respiratory and critical care medicine.

[5]  K. Kalantar-Zadeh,et al.  Outcome predictability of biomarkers of protein-energy wasting and inflammation in moderate and advanced chronic kidney disease. , 2009, The American journal of clinical nutrition.

[6]  L. Sharples,et al.  Disease‐Specific Survival Benefit of Lung Transplantation in Adults: A National Cohort Study , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[7]  M. Russo,et al.  Despite decreased wait-list times for lung transplantation, lung allocation scores continue to increase. , 2009, Chest.

[8]  A. Karlamangla,et al.  Serum albumin concentration and waiting list mortality in idiopathic interstitial pneumonia. , 2009, Chest.

[9]  R. Porcher,et al.  Determinants of the survival benefit of lung transplantation in patients with chronic obstructive pulmonary disease. , 2008, American journal of respiratory and critical care medicine.

[10]  R. Barr,et al.  Racial differences in waiting list outcomes in chronic obstructive pulmonary disease. , 2008, American journal of respiratory and critical care medicine.

[11]  Eva L. H. Tsui,et al.  Prognostication in severe acute respiratory syndrome: A retrospective time‐course analysis of 1312 laboratory‐confirmed patients in Hong Kong , 2007, Respirology.

[12]  J. Christie,et al.  Effects of lung allocation score on waiting list rankings and transplant procedures. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[13]  T. Boonpipattanapong,et al.  Preoperative Carcinoembryonic Antigen and Albumin in Predicting Survival in Patients With Colon and Rectal Carcinomas , 2006, Journal of clinical gastroenterology.

[14]  G. Beck,et al.  C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. , 2005, Kidney international.

[15]  R. Barst,et al.  New predictors of outcome in idiopathic pulmonary arterial hypertension. , 2005, The American journal of cardiology.

[16]  G. Kaysen,et al.  POOR NUTRITIONAL STATUS AND INFLAMMATION: Serum Albumin: Relationship to Inflammation and Nutrition , 2004, Seminars in dialysis.

[17]  L. Ferrucci,et al.  Peripheral Blood Markers of Inflammation Predict Mortality and Functional Decline in High‐Functioning Community‐Dwelling Older Persons , 2002, Journal of the American Geriatrics Society.

[18]  T. Harris,et al.  The Prognostic Value of Serum Albumin in Healthy Older Persons with Low and High Serum Interleukin‐6 (IL‐6) Levels , 2000, Journal of the American Geriatrics Society.

[19]  J. Ix,et al.  The Predictive Value of Combined Hypoalbuminemia and Hypocholesterolemia in High Functioning Community‐Dwelling Older Persons: MacArthur Studies of Successful Aging , 1999, Journal of the American Geriatrics Society.

[20]  C. Sen,et al.  Antioxidant regulation of phorbol ester-induced adhesion of human Jurkat T-cells to endothelial cells. , 1998, Free radical biology & medicine.

[21]  R. Novick,et al.  Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease , 1998, The Lancet.

[22]  J. Joles,et al.  Hypoalbuminemia causes high blood viscosity by increasing red cell lysophosphatidylcholine. , 1997, Kidney international.

[23]  T. Peters,et al.  Serum and urine albumin: a progress report on their measurement and clinical significance. , 1997, Clinica chimica acta; international journal of clinical chemistry.

[24]  R. Baumgartner,et al.  Serum albumin is associated with skeletal muscle in elderly men and women. , 1996, The American journal of clinical nutrition.

[25]  R. Foley,et al.  Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. , 1996, Journal of the American Society of Nephrology : JASN.

[26]  J. Sorkin,et al.  Serum albumin level and physical disability as predictors of mortality in older persons. , 1994, JAMA.

[27]  M. Wick,et al.  Serum albumin concentration-related Health Care Financing Administration quality assurance criterion is method-dependent: revision is necessary. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[28]  J V Castell,et al.  Interleukin-6 and the acute phase response. , 1990, The Biochemical journal.

[29]  O. Miettinen,et al.  Theoretical Epidemiology: Principles of Occurrence Research in Medicine. , 1987 .

[30]  L. Ward,et al.  Nutritional rehabilitation in cystic fibrosis: controlled studies of effects on nutritional growth retardation, body protein turnover, and course of pulmonary disease. , 1986, The Journal of pediatrics.

[31]  Sander Greenland,et al.  Theoretical Epidemiology: Principles of Occurrence Research in Medicine , 1986 .

[32]  R. Tibshirani,et al.  Generalized additive models for medical research , 1995, Statistical methods in medical research.

[33]  H. Greene,et al.  Enteral-tube feeding as adjunct therapy in malnourished patients with cystic fibrosis: a clinical study and literature review. , 1986, The American journal of clinical nutrition.

[34]  C. Wright,et al.  Protective effect of taurine, zinc and tocopherol on retinol-induced damage in human lymphoblastoid cells. , 1984, The Journal of nutrition.

[35]  R. Jacob,et al.  Some biochemical indices of nutrition in treated cystic fibrosis patients. , 1981, The American journal of clinical nutrition.

[36]  R. Hoffenberg,et al.  Regulation of Albumin Synthesis and Catabolism by Alteration of Dietary Protein , 1968, Nature.

[37]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[38]  Michael John Smith,et al.  The impact of the lung allocation score on short-term transplantation outcomes: a multicenter study. , 2008, The Journal of thoracic and cardiovascular surgery.

[39]  Tamara B Harris,et al.  Lower serum albumin concentration and change in muscle mass: the Health, Aging and Body Composition Study. , 2005, The American journal of clinical nutrition.

[40]  M. A. Rothschild,et al.  Serum albumin , 2005, The American Journal of Digestive Diseases.

[41]  Stefan Sperlich,et al.  Generalized Additive Models , 2014 .

[42]  C. Weinberg,et al.  Use and misuse of population attributable fractions. , 1998, American journal of public health.